Experimental prostate cancer drug may improve COVID-19 survival
[ad_1] An experimental prostate cancer drug improved the survival of hospitalised COVID-19 patients in Brazil in a clinical trial, researchers reported on Tuesday on medRxiv ahead of peer review. The [...]

